Tomas Eriksson

Title: Innovations and Contributions of Inventor Tomas Eriksson

Introduction

Tomas Eriksson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on the development of compounds that have therapeutic applications.

Latest Patents

Among his latest patents, one invention provides compounds of general formula (D), where m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7, and R8 are defined in the specification. This invention includes processes for their preparation, pharmaceutical compositions containing them, and their use in therapy. Another significant patent involves benzimidazol derivatives that modulate chemokine receptors, providing compounds of general formula (I) with specific definitions for A, X, m, R, N, R, Z, Z, Q, R, R, R, R, R, R, t, and R. This invention also encompasses processes for preparation, pharmaceutical compositions, and therapeutic applications.

Career Highlights

Tomas Eriksson has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Tomas has collaborated with notable colleagues such as Magnus Leif Lindvall and Tomas Klingstedt. These partnerships have likely enhanced his research and development efforts.

Conclusion

Tomas Eriksson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact therapeutic advancements in the industry.